$Can-Fite BioPharma (CANF.US)$Benzinga· 2 mins ago Rhe FDA Has Granted Investigational New Drug Clearance For Can-Fite Biopharma's Namodenoson, For Metabolic Dysfunction-Associated Steatohepatitis, Also Known As Non-alcoholic Steatohepatitis, For The Company's Ongoing Phase 2B Study
Can-Fite BioPharma股票討論區
康輝生物製藥有限公司 (紐約證券交易所美國:CANF) (TASE: CANF)這是一家致力於開發腫瘤和炎症疾病的創新治療方法的生物技術公司,公布了有關其小分子藥物 Namodenoson 的新發現。這些最近的發現揭示了納摩登的機制...
Rhe FDA Has Granted Investigational New Drug Clearance For Can-Fite Biopharma's Namodenoson, For Metabolic Dysfunction-Associated Steatohepatitis, Also Known As Non-alcoholic Steatohepatitis, For The Company's Ongoing Phase 2B Study
新聞
Can-Fite 收到歐洲專利局通過 CF602 治療勃起功能障礙的津貼通知
穆穆 24 小時全天候· 1 分鐘前
暫無評論